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Abstract
Background: The purpose of the present study was to elucidate the mechanisms that may underlie the
sensitization of trigeminal spinal subnucleus caudalis (Vc) and upper cervical spinal cord (C1-C2) neurons to heat or
cold stimulation of the orofacial region following glutamate (Glu) injection.
Results: Glu application to the tongue or whisker pad skin caused an enhancement of head-withdrawal reflex and
extracellular signal-regulated kinase (ERK) phosphorylation in Vc-C2 neurons. Head-withdrawal reflex and ERK
phosphorylation were also enhanced following cold stimulation of the tongue but not whisker pad skin in Glu-
injected rats, and the head-withdrawal reflex and ERK phosphorylation were enhanced following heat stimulation
of the tongue or whisker pad skin. The enhanced head-withdrawal reflex and ERK phosphorylation after heat
stimulation of the tongue or whisker pad skin, and those following cold stimulation of the tongue but not whisker
pad skin were suppressed following ionotropic glutamate receptor antagonists administration into the tongue or
whisker pad skin. Furthermore, intrathecal administration of MEK1/2 inhibitor PD98059 caused significant
suppression of enhanced head-withdrawal reflex in Glu-injected rats, heat head-withdrawal reflex in the rats with
Glu injection into the tongue or whisker pad skin and cold head-withdrawal reflex in the rats with Glu injection
into the tongue.
Conclusions: The present findings suggest that peripheral Glu receptor mechanisms may contribute to cold
hyperalgesia in the tongue but not in the facial skin, and also contribute to heat hyperalgesia in the tongue and
facial skin, and that the mitogen-activated protein kinase cascade in Vc-C2 neurons may be involved in these Glu-
evoked hyperalgesic effects.
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Background
It is well known from human psychophysical studies
that thermal and mechanical sensitivity of the tongue is
different from that of the facial skin [1-4]. Cold and
heat sensory thresholds are significantly higher in the
tongue compared to the facial skin. The pain threshold
is also higher in tongue compared to the facial skin. Pre-
vious histological studies have also reported that cuta-
neous tissues are covered by orthokeratinized tissues,
whereas mucosal membranes are covered by parakerati-
nized tissues, and mucosal surfaces are highly
moisturized [5]. Furthermore, a larger number of small
salivary glands are distributed in the intraoral mucosa
but not in the facial skin [6]. These human psychophysi-
cal and histological data strongly suggest that thermal
and mechanical sensory mechanisms are different
between intraoral tissues and the facial skin.
It is also known that tissue inflammation or injury of
intraoral tissues causes severe pain, such as burning
pain, referred pain or chronic pain [7-9]. Following per-
ipheral tissue inflammation or injury, a variety of inflam-
matory mediators, neuropeptides or adenosine
triphosphate (ATP) is released from the inflamed or
injured tissue [10,11]. These molecules bind specific
receptors in the primary afferent neurons, resulting in
sensitization of primary afferent fibers. It has also been
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activate primary afferent nociceptors following its
release from inflamed or injured tissues [12-17]. The
elevated concentration of Glu has also been detected in
human tissues in association with chronic non-inflam-
matory pain conditions and may contribute to chronic
deep tissue pain in humans [18,19]. It has also been
reported that N-methyl-d-aspartate (NMDA) receptor
antagonist ketamine injection into the temporomandibu-
lar joint (TMJ) causes significant attenuation of the Glu-
induced TMJ pain in human subjects, suggesting that
the ionotropic glutamate receptor is involved in Glu-
induced TMJ pain [20]. These findings also suggest that
Glu is released from the peripheral tissues after tissue
inflammation or injury and binds to Glu receptor a-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) or NMDA receptor subtypes. This mechanism
may be involved in the enhancement of primary afferent
excitability. Some previous animal studies have revealed
that the injection of Glu into the tongue [21], jaw mus-
cles or TMJ sensitizes small-diameter primary afferent
neurons innervating deep orofacial tissues and induces
nociceptive processes in the central nervous system
[22-25]. These findings raise the possibility that Glu
may also be released peripherally after orofacial inflam-
mation or injury and may be involved in enhancing the
activity of primary afferents innervating orofacial tissues
such as the tongue and facial skin. However, whether
peripheral Glu receptors are involved in orofacial ther-
mal hyperalgesia has not been investigated.
Extracellular signal-regulated kinase (ERK) is known
as one of the mitogen-activated protein kinases
(MAPKs) [26-28]. ERK in dorsal root ganglion (DRG)
and spinal dorsal horn (DH) neurons is phosphorylated
within 10 min following peripheral noxious stimuli and
the number of phosphorylated ERK-immunoreactive
(pERK-IR) cells increases in the DRG and DH as nox-
ious stimulus intensity increases [29,30]. Recently, it has
been reported that ERK is phosphorylated in many neu-
rons in trigeminal spinal subnucleus caudalis (Vc) and
upper cervical spinal cord (C1-C2) dorsal horn within 5
min following noxious stimulation of orofacial tissues
[31,32]. These findings suggest that the activation of
neurons following noxious orofacial stimulation is
reflected in the phosphorylation of ERK in Vc and C1-
C2 neurons, and also indicate that the ERK phosphory-
lation in Vc and C1-C2 neurons is a reliable marker of
nociceptive neurons activated by orofacial noxious
stimuli.
Thus, the aim of this study was to clarify whether per-
ipheral Glu receptors may be involved in the central
sensitization of Vc and C1-C2 neurons activated by nox-
ious heat or cold stimulation of these orofacial tissues
by using immunohistochemical technique to detect ERK
phosphorylation in Vc and C1-C2 neurons following
thermal stimulation of the tongue or whisker pad skin.
Results
Head-withdrawal reflex
The head-withdrawal latency following submucosal or
subcutaneous Glu injection into the tongue or whisker
pad skin, respectively, was significantly shorter com-
pared to that following vehicle injection (Figure 1A).
Furthermore, the head-withdrawal threshold to heat sti-
mulation of the tongue or whisker pad skin was signifi-
cantly lower in Glu-injected rats compared to that of
vehicle-injected rats (tongue, Glu-injected rats: 45.47 ±
1.27°C, vehicle-injected rats: 51.28 ± 1.19°C; whisker pad
skin, Glu-injected rats: 49.79 ± 1.46°C, vehicle-injected
rats: 55.24 ± 1.45°C) (Figure 1B). On the other hand, the
head-withdrawal threshold to cold stimulation of the
tongue and whisker pad skin was different. Head-with-
drawal threshold to cold stimulation of the whisker pad
skin with Glu injection into the whisker pad skin was
not different from that of vehicle-injected rats, whereas
the head-withdrawal threshold temperature to cold sti-
mulation of the tongue was significantly higher in Glu-
injected rats compared to vehicle-injected rats (tongue,
Glu-injected rats: 5.78 ± 1.92°C, vehicle-injected rats:
0.52 ± 0.34°C; whisker pad skin, Glu-injected rats: 3.49
± 1.19°C, vehicle-injected rats: 2.95 ± 0.91°C) (Figure
1C).
The head-withdrawal threshold to heat or cold stimu-
lation of the tongue and heat stimulation of the whisker
pad skin was also measured in the contralateral side to
Glu injection. We could not observe any differences in
head-withdrawal thresholds to heat or cold stimulation
of the contralateral tongue and heat stimulation of the
contralateral whisker pad skin compared to those of
vehicle injections (Figure 1D, E).
ERK phosphorylation in Vc and C1-C2 neurons and effect
of MEK 1/2 inhibitor on ERK phosphorylation
In order to define the peak time point when the largest
number of pERK-IR neurons was noted, the time course
of changes in the number of pERK-IR neurons in Vc
and C1-C2 was analyzed following subcutaneous injec-
tion of Glu into the whisker pad skin. ERK phosphoryla-
tion in Vc and C1-C2 neurons was detected within 2
min and peaked at 5 min following subcutaneous Glu
(0.5 M) injection into the whisker pad skin (Figure 2A).
Only a small number of pERK-IR cells was observed at
10 min after subcutaneous Glu (0.5 M) injection into
the whisker pad skin. All pERK-IR cells also showed
NeuN immunoreactivity, indicating that pERK-IR cells
observed in this study were neurons (Figure 2B-D). The
number of pERK-IR neurons expressed in Vc and C1-
C2 after Glu injection to the whisker pad skin was
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Figure 1 Head-withdrawal latency to Glu or vehicle (Veh) injection into the tongue or whisker pad skin, head-withdrawal threshold to
heat or cold stimulation of the tongue or whisker pad skin in the rats with Glu or Veh injection into the tongue or whisker pad skin.
The onset latency of EMG activity was recorded from the splenius capitis muscle following Glu or Veh injection into the tongue or whisker pad
skin, and the head-withdrawal threshold to heat or cold stimulation of the tongue or whisker pad skin was also measured as the suprathreshold
stimulus intensity evoking EMG activity. A: Mean head-withdrawal latency following Glu or Veh injection into the tongue or whisker pad skin, B
and C: Mean head-withdrawal threshold following heat or cold stimulation of the tongue or whisker pad skin in the rat with Glu or Veh
injection, respectively. Inset diagrams in each panel indicate EMG activities recorded from the splenius capitis muscle following Glu injection into
the whisker pad skin (A), that following heat or cold stimulation of the whisker pad skin in the Glu injected rat (B and C). The head-withdrawal
threshold to heat or cold stimulation of the tongue contralateral side in the rats with Glu or Veh injection into the tongue (D) and heat
stimulation of the whisker pad skin contralateral side in the rats with Glu or Veh injection into the whisker pad skin (E). *: p < 0.05, **: p < 0.01.
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Figure 2 Time-course change in the number of pERK-IR cells in the Vc and C1-C2 and the effect of i.t administration of PD98059 on
ERK phosphorylation following subcutaneous Glu injection into the whisker pad skin. A: The number of pERK-IR cells was counted at 2, 5
and 10 min after Glu injection into the whisker pad skin. B, C and D: Photomicrographs of pERK-IR cells (B), NeuN positive cells (C) and the
photomicrograph of B merged with C (D). E: Mean number of pERK-IR cells in Vc and C1-C2 five min after Glu injection into the whisker pad
skin in the rats with i.t. administration of PD98059 or Veh. The arrows n B, C and D indicate pERK-IR and/or NeuN positive neurons induced by
Glu injection. **: p < 0.01.
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injected rats compared to that of vehicle-injected rats
(Figure 2E).
A large number of pERK-IR neurons was restricted to
the superficial laminae of the dorsal portion of the Vc
after heat or cold stimulation of the tongue in Glu- or
vehicle-injected rats (Figure 3A-D). Many were also
observed in the superficial laminae of the Vc after heat
or cold stimulation applied to the whisker pad skin in
0.5 M Glu- or vehicle-injected rats as indicated by the
arrows (Figure 3E-H).
The rostro-caudal distribution of the pERK-IR neu-
rons after heat stimulation (50°C) of the tongue or whis-
ker pad skin with vehicle or Glu injection is illustrated
in Figure 4. The number of pERK-IR neurons peaked at
the obex level after heat stimulation of the tongue fol-
lowing submucosal injection of Glu into the tongue
(Figure 4A-C). On the other hand, the number peaked
at 1440 μm caudal to the obex after heat stimulation of
the whisker pad skin following Glu injection into the
whisker pad skin (Figure 4D-F). The number of pERK-
IR neurons following noxious heat stimulation of the
tongue was significantly greater in 0.5 M Glu-injected
rats than in those receiving 0.1 M Glu-injected or in
vehicle-injected rats (Figure 4G), and that following heat
stimulation of the whisker pad skin was significantly
greater in 0.5 M Glu-injected rats than that in vehicle-
injected rats (Figure 4H).
The number of pERK-IR neurons also peaked at the
obex level after cold stimulation (5°C) of the tongue fol-
lowing submucosal Glu (0.5 M) injection into the ton-
gue (Figure 5A-C), whereas the number peaked at 1440
μm caudal to the obex after cold stimulation of the
whisker pad skin following Glu injection into the whis-
ker pad skin (Figure 5D-F). After cold stimulation of the
tongue in vehicle- or Glu-injected rats, the number of
pERK-IR neurons was significantly larger in 0.5 M Glu-
injected rats following cold stimulation of the tongue
compared to that of vehicle- or 0.1 M Glu-injected rats
(Figure 5G). On the other hand, no differences in the
number of pERK-IR neurons were observed between
these three groups of vehicle- or Glu-injected rats after
cold stimulation of the whisker pad skin (Figure 5H).
The head-withdrawal threshold and expression of
pERK-IR cells in Vc and C1-C2 to heat or cold stimula-
tion of the tongue in whisker pad Glu-injected rats and
that to heat stimulation of the whisker pad skin in ton-
gue Glu-injected rats were also analyzed, and we could
not observe any significant differences in the head-with-
drawal threshold and expression of the pERK-IR cells
between Glu-injected and vehicle-injected rats (Figure
6A-F).
Effect of Glu receptor antagonists on head-withdrawal
reflex and ERK phosphorylation
The NMDA receptor antagonist, APV (1 mM) or non-
NMDA Glu receptor antagonist, CNQX (10 μM) or
v e h i c l ew a si n j e c t e di n t ot h et o n g u eo rw h i s k e rp a d
skin. Five min later, 0.5 M Glu was injected at the same
site where APV, CNQX or vehicle was injected, and the
head-withdrawal latency was measured. The head-with-
drawal latency to the onset of Glu injection into the
tongue or whisker pad skin was significantly longer in
APV- or CNQX-injected rats compared to vehicle-
Figure 3 Photomicrographs of pERK-IR cells in Vc after heat or cold stimulation of the tongue (A, B, C and D) or whisker pad skin (E,
F, G and H) in the rats with Glu or Veh injection into the tongue or whisker pad skin. Arrows in A, B, E and G indicate the areas where
pERK-IR cells were observed.
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Page 4 of 14injected rats (Figure 7A). In Glu-injected rats, head-
withdrawal threshold to heat stimulation of the tongue
or whisker pad skin was also significantly higher in
APV- or CNQX-injected rats compared to vehicle-
injected group (tongue, APV-injected rats: 51.89 ± 1.59°
C, CNQX-injected rats: 53.47 ± 1.37°C, vehicle-injected
rats: 46.19 ± 1.63°C; whisker pad skin, APV-injected
rats: 57.03 ± 0.68°C, CNQX-injected rats: 56.51 ± 0.43°
C, vehicle-injected rats: 48.68 ± 2.13°C) (Figure 7B). The
threshold temperature to evoking head-withdrawal to
cold stimulation of the tongue was also significantly
lower in APV- or CNQX-injected rats with Glu
injection compared to those in vehicle-injected rats with
Glu injection, whereas the head-withdrawal threshold to
cold stimulation of the whisker pad skin was not signifi-
cantly different in Glu-injected rats following APV,
CNQX or vehicle injection (tongue, APV-injected rats:
0.45 ± 0.25°C, CNQX-injected rats: 0.73 ± 0.63°C, vehi-
cle-injected rats: 6.93 ± 1.33°C; whisker pad skin, APV-
injected rats: 0.51 ± 0.51°C, CNQX-injected rats: 0.23 ±
0.23°C, vehicle-injected rats: 3.13 ± 1.40°C) (Figure 7C).
The number of pERK-IR neurons following heating of
the tongue or whisker pad skin was significantly smaller
in Vc and C1-C2 of Glu-injected rats following APV or
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Figure 4 The rostro-caudal distribution of pERK-IR cells in Vc and C1-C2 following heat stimulation of the tongue (A, B and C) or
whisker pad skin (D, E and F) in the rats with Glu (0.1 M or 0.5 M) or Veh injection into the tongue or whisker pad skin. G and H:
Mean number of pERK-IR cells in Vc and C1-C2 following heat stimulation of the tongue (G) or whisker pad skin (H) in the Glu- or Veh-injected
rats. Ipsi indicates ipsilateral side to Glu or Veh injection. Contra indicates contralateral side to Glu or Veh injection in this and following figures. *:
p < 0.05, **: p < 0.01.
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Page 5 of 14CNQX injection compared to that following vehicle
injection (Figure 8A). The number of pERK-IR neurons
following cold stimulation of the tongue was signifi-
cantly smaller in Glu-injected rats after APV or CNQX
injection compared to those after vehicle injection (Fig-
ure 8B), but was not significantly different between APV
and CNQX-injected and vehicle-injected rats following
cold stimulation of the whisker pad skin (Figure 8B).
Effect of MEK1/2 inhibitor on head-withdrawal reflex
We also studied the effect of the i.t. administration of
PD98059 on head-withdrawal reflex in Glu-injected rats.
The head-withdrawal latency after Glu injection into the
tongue or whisker pad skin was significantly longer in
PD98059-injected rats compared to vehicle-injected rats
(Figure 9A). The head-withdrawal threshold to heat sti-
mulation of the tongue or whisker pad skin was signifi-
cantly higher in PD98059-injected rats compared to
vehicle-injected rats (tongue, PD98059-injected rats:
52.22 ± 1.28°C, vehicle-injected rats: 46.44 ± 0.83°C;
whisker pad skin, PD98059-injected rats: 55.24 ± 1.46°C,
vehicle-injected rats: 50.82 ± 0.98°C) (Figure 9B). The
head-withdrawal threshold to cold stimulation of the
tongue was also significantly lower in PD98059-injected
rats compared with that of vehicle-injected rats, whereas
that to cold stimulation of the whisker pad skin was not
significantly different between PD98059-injected rats
and vehicle-injected (tongue, PD98059-injected rats:
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Figure 5 The rostro-caudal distribution (A, B, C, D, E and F) and mean number (G and H) of pERK-IR cells in Vc and C1-C2 following
cold stimulation of the tongue (A, B, C and G) or whisker pad skin (D, E, F and H) in the rats with Glu (0.1 M or 0.5 M) or vehicle
injection into the tongue or whisker pad skin. Note that significantly larger number of pERK-IR cells was observed in tongue Glu-injected rats
compared with that in whisker Glu-injected rats. *: p < 0.05, **: p < 0.01.
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Page 6 of 142.03 ± 1.22°C; vehicle-injected rats: 7.54 ± 1.95°C; whis-
ker pad skin, PD98059-injected rats: 1.28 ± 0.81°C; vehi-
cle-injected rats: 2.50 ± 1.11°C) (Figure 9C).
Discussion
We have provided the first documentation of the possi-
ble involvement of peripheral Glu receptors in heat
hyperalgesia of the tongue and whisker pad skin, and in
cold hyperalgesia of the tongue but not whisker pad
skin. Glu injection into the tongue or whisker pad skin
caused significant enhancement of head-withdrawal
reflex. The head-withdrawal reflex was also significantly
enhanced following cold stimulation of the tongue in
rats receiving Glu injection into the tongue, but was not
affected by cold stimulation of the whisker pad skin in
rats receiving Glu injection into the whisker pad skin.
The enhancement of heat and cold head-withdrawal
reflex in tongue Glu-injected rats was suppressed fol-
lowing peripheral administration of AMPA or NMDA
receptor antagonist. Furthermore, many pERK-IR neu-
rons were observed in Vc and C1-C2 following heat sti-
mulation of the tongue or whisker pad skin with Glu
injection, whereas a greater number of pERK-IR neurons
was expressed after cold stimulation of the tongue but
not whisker pad skin in Glu-injected rats. The increased
number of pERK-IR cells following heat or cold
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Figure 6 The head-withdrawal threshold to heat or cold stimulation of the tongue in the rats with 0.5 M Glu or vehicle injection into
the whisker pad skin (A, B) and heat stimulation of the whisker pad skin in the rats with 0.5 M Glu or Veh injection into the tongue
(C). Mean number of pERK-IR cells in Vc and C1-C2 following heat or cold stimulation of the tongue in the rats with 0.5 M Glu or vehicle
injection into the whisker pad skin (D, E) and heat stimulation of the whisker pad skin in the rats with 0.5 M Glu or vehicle injection into the
tongue (F).
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Page 7 of 14stimulation of the tongue or whisker pad skin in Glu-
injected rats was significantly suppressed by APV or
CNQX administration. The increased number of pERK-
IR cells after cold stimulation of the tongue was also
significantly suppressed following APV or CNQX
administration, whereas that after cold stimulation of
the whisker pad skin was not altered after APV or
CNQX administration. The enhanced heat head-with-
drawal reflex in the tongue or whisker pad skin, and
enhanced cold head-withdrawal reflex in the tongue
were significantly suppressed by i.t. administration of
PD98059 in Glu-injected rats. These findings suggest
that peripheral Glu receptors are differentially involved
in mechanisms underlying thermal hyperalgesia in ton-
gue and whisker pad skin.
Enhancement of head-withdrawal reflex following Glu-
treatment
We documented that the head-withdrawal latency was
significantly decreased following Glu injection into the
tongue or whisker pad skin compared with that follow-
ing vehicle injection. The enhanced head-withdrawal
reflex in the rats with Glu injection was suppressed by
peripheral injection of CNQX, APV or i.t.
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Figure 7 Head-withdrawal latency to 0.5 M Glu and Veh, 1 mM APV or 10 μM CNQX injections into the tongue or whisker pad skin
(A), head-withdrawal threshold to heat (B) or cold (C) stimulation of the tongue or whisker pad skin in the rats with Veh, APV or
CNQX injections into the tongue or whisker pad skin. A: Mean head-withdrawal latency following Glu or Veh injection into the tongue or
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250
200
150
100
50
0
Mean number of pERK-IR cells
;ϮϳƐĞĐƟŽŶƐͬĂŶŝŵĂůͿ
250
200
150
100
50
0 Veh APV CNQX
0.5 M Glu + Heat (50oͿ
Veh APV CNQX
0.5 M Glu + Cold (5oͿ
͗tŚŝƐŬĞƌƉĂĚƐŬŝŶ
: Tongue
A B
**
**
*
*
**
**
Figure 8 Mean number of pERK-IR cells in Vc and C1-C2 following heat (A) or cold (B) stimulation of the tongue or whisker pad skin
in the rats with 0.5 M Glu and Veh, 1 mM APV or 10 μM CNQX injections into the tongue or whisker pad skin. Note that the mean
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Page 8 of 14administration of PD98059. Glu injection into the
human masseter muscle or TMJ is known to cause a
severe pain around the injection sites as well as over a
wide area of the lateral facial skin [18,20,33]. Some pre-
vious studies have also reported that Glu injection into
the TMJ causes the strong enhancement of reflex
responses associated with increased masseter and digas-
tric muscle activities in rats [34,35]. It has also been
reported that trigeminal afferent activity is significantly
increased following Glu injection into the masseter mus-
cle or TMJ [17,36]. They have also reported that periph-
eral administration of the NMDA receptor antagonist
causes significant reduction of primary afferent activity,
suggesting that NMDA receptor mechanism is involved
in peripheral sensitization following Glu injection into
the masseter muscle [37]. Our head-withdrawal reflex
data is consistent with these results since head-withdra-
wal reflex is significantly enhanced following submuco-
sal or subcutaneous Glu injection respectively into the
tongue or whisker pad skin, supporting these recent
findings that Glu activates craniofacial nociceptors.
Further studies are needed to evaluate the functional
differences of AMPA and NMDA receptors involved in
Glu-induced peripheral thermal sensitization.
Furthermore, we could not observe any obvious extra-
territorial hypersensitivity to heat or cold stimulation of
the tongue in the rats with Glu injection into the whis-
ker pad skin and heat stimulation of the whisker pad
skin in Glu injection into the tongue. This suggests that
peripheral Glu injection may cause allodynia or hyperal-
gesia in the localized area where Glu was injected.
Tongue heat- or cold-hyperalgesia after Glu treatment
We observed that injection of APV or CNQX into the
tongue or whisker pad skin significantly depressed the
Glu-induced head-withdrawal reflex and enhancement
of heat head-withdrawal reflex, and that head-withdra-
wal reflex to cold stimulation of the tongue but not
whisker pad skin was significantly reduced following
peripheral injection of CNQX or APV in Glu-injected
rats. These findings suggest that Glu receptors are dif-
ferentially involved in thermal sensitization of tongue
versus facial skin.
It has been reported that transient receptor potential
(TRP) vanilloid 1 (TRPV1) and TRP melastatin 8
(TRPM8) or TRP ankyrin 1 (TRPA1) are distributed in
C-fiber DRG neurons and are involved in response to
heat or cold stimulation of the neuronal receptive fields,
respectively [38-40]. Some previous anatomical studies
have also documented that TRPV1 and Glu receptors
are co-expressed in C-fiber trigeminal ganglion (TG)
neurons innervating the whisker pad skin or tongue
[37], suggesting that these receptors co-expressed in TG
neurons are involved in sensitization of heat-responsive
C-fibers. It has also been documented that AMPA and
NMDA receptors are expressed in DRG neurons and
accumulate in C-fiber terminals [41-44]. Although our
study did not determine the location of the peripheral
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Page 9 of 14ionotropic glutamate receptors, which have been shown
to occur on afferent terminals as well as on other per-
ipheral tissue cells [45,46], nonetheless the above-men-
tioned findings along with our own data suggest that
peripheral Glu receptors are differentially involved in
sensitization of heat and cold receptors in tongue versus
whisker pad skin. Together with the previous primary
afferent data, our results also suggest the following two
possible mechanisms: One mechanism is that cold and
heat receptors are co-expressed with Glu receptors in
C-fiber TG neurons innervating the tongue, whereas TG
neurons with heat and Glu receptors innervate the facial
skin, resulting in the enhancement of cold and heat
responses of Vc and C1-C2 neurons after Glu injection
into the tongue, and the enhancement of heat response
of those neurons after Glu injection into the facial skin,
and the other mechanism is that these receptors are
expressed in different primary afferent neurons innervat-
ing the tongue or facial skin and that converge onto Vc
and C1-C2 neurons. In the case of the whisker pad skin,
our data suggest that cold and Glu receptors are not co-
expressed in TG neurons, and that they are expressed in
different primary afferent neurons contacting on differ-
ent Vc and C1-C2 neurons. Further support for the dif-
ferential involvement of Glu and cold receptors on
tongue versus facial skin comes from our ERK data.
Involvement of ERK phosphorylation in tongue
hyperalgesia
A large number of pERK-IR neurons was expressed in
the Vc and C1-C2 after Glu injection into the tongue or
whisker pad skin. The number of pERK-IR neurons fol-
lowing heat stimulation of the tongue or whisker pad
skin was significantly greater in tongue or whisker Glu-
injected rats compared with that in vehicle-injected rats.
The ERK phosphorylationi nV ca n dC 1 - C 2n e u r o n s
was significantly enhanced following cold stimulation of
the tongue in tongue Glu-injected rats, but were not
affected by cold stimulation of the whisker pad skin in
whisker Glu-injected rats. The ERK phosphorylation fol-
lowing heat stimulation of the tongue or whisker pad
skin and cold stimulation of the tongue was significantly
suppressed following subcutaneous or submucosal injec-
tion of APV or CNQX. We also observed that i.t.
administration of MEK1/2 inhibitor PD98059 caused
significant inhibition of the head-withdrawal reflex after
Glu injection itself into the tongue or whisker pad skin,
and also inhibited the heat head-withdrawal reflex and
ERK phosphorylation in Glu-injected rats. Cold head-
withdrawal reflex after Glu injection into the tongue but
not whisker pad skin was also significantly suppressed
by i.t. PD98059 administration.
It is well known that ERK is phosphorylated in DRG
and TG neurons after noxious stimulation of the hind
paw via Ca
2+ influx [47], suggesting that i.t. PD98059
administration likely blocks Ca
2+ influx in Vc and C1-
C2 neurons and TG primary afferent terminals which
would contribute to the block of heat-evoked head-with-
drawal reflex with Glu injection into the tongue or whis-
ker pad skin, and to the blockade of the cold-evoked
head-withdrawal reflex in tongue Glu-injected rats.
We could not observe any differences in the suppres-
sive effect on head-withdrawal reflex to heat stimulation
of the tongue and whisker pad skin and ERK phosphor-
ylation between CNQX and APV administration in Glu-
injected rats. On the other hand, the effect of CNQX
and APV on cold head-withdrawal reflex in Glu-injected
rats was different between the tongue and whisker pad
skin. It is likely that AMPA and NMDA receptor sub-
types are similarly involved in Glu-induced ERK phos-
phorylation in Vc and C1-C2 neurons following heating
the tongue and whisker pad skin, but are differentially
involve in Glu-induced ERK phosphorylation following
noxious cold stimulation of the tongue and whisker pad
skin, consistent with our head-withdrawal reflex
findings.
Conclusions
The present findings revealed that Glu application to the
tongue or whisker pad skin caused an enhancement of
head-withdrawal reflex and ERK phosphorylation in Vc
and C1-C2 neurons to heat stimulation; head-withdra-
wal reflex and ERK phosphorylation were also enhanced
following cold stimulation of the tongue but not whisker
pad skin in Glu-injected rats. These findings suggest
that peripheral Glu receptor mechanisms may contri-
bute to cold hyperalgesia in the tongue but not in the
facial skin, and also contribute to heat hyperalgesia in
the tongue and facial skin, and that the mitogen-acti-
vated protein kinase cascade in Vc and C1-C2 neurons
may be involved in these Glu-evoked hyperalgesic
effects.
Methods
Animals
A total of 408 male Sprague-Dawley rats weighting 200-
250 g were used. This study was approved by the Ani-
mal Experimentation Committee at the Nihon Univer-
sity. All surgeries and animal care were conducted in
accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals and the
guidelines for Institutional Animal Care, and the guide-
lines of the International Association for the Study of
Pain [48].
Head-withdrawal reflex testing
Rats were lightly anesthetized with 2% isoflurane
(Mylan, Canonsburg, PA) with 100% O2.A sp r e v i o u s l y
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Page 10 of 14described [49], bipolar enamel-coated silver wire electro-
des (Narishige, Tokyo, Japan) were placed in the left
splenius capitis muscle for electromyographic (EMG)
recordings to detect the time point of head movement
(inter-electrode distance: 5-6 mm). Glu (Sigma-Aldrich,
St. Louis, MI) was dissolved in isotonic saline to pro-
duce a 0.5 M Glu solution. Isotonic saline was used as
the vehicle control. Five min after 0.5 M Glu (10 μl) or
vehicle (10 μl) was injected with 27 gage fine needle
into center of the left whisker pad skin or lateral edge
of the tongue subcutaneously (depth: 2 mm), heat (1°C/
sec, cut-off temperature: 60°C) or cold (1°C/sec, cut-off
temperature: 0°C) stimulation was applied to the same
skin or tongue site received Glu or vehicle injection (n
= 6 in each group). The thermal stimuli were delivered
by a contact thermal probe (5 mm in diameter, adapting
temperature: 35°C, Intercross, Tokyo, Japan) in the ipsi-
lateral or contralateral side to the Glu or vehicle injec-
tion. The head-withdrawal latency to Glu or vehicle
injection into the whisker pad skin or tongue was calcu-
lated by measuring the onset latency of splenius capitis
muscle EMG activity after Glu or vehicle injection. The
head-withdrawal threshold to heat or cold stimulation 5
min after Glu injection was determined as the stimulus
intensity when small EMG activity could be recorded
after thermal stimulation as illustrated in the inset of
Figure 1A. Measurement of the head-withdrawal latency
to Glu injection or vehicle and head-withdrawal thresh-
old following thermal stimulation in Glu-injected rats
was conducted only once in each rat by the same inves-
tigator to ensure standardization.
The head-withdrawal threshold to heat or cold stimu-
lation of the tongue in whisker pad Glu-injected rats
and heat stimulation of the whisker pad skin in tongue
Glu-injected rats were also measured (n = 5 in each
group).
Although we injected the very small amount of Glu
into the whisker pad or tongue, we cannot rule out the
possibility of Glu entering in other body areas through
the systemic circulation.
pERK immunohistochemistry
To determine the time course and peak time of ERK
phosphorylation, rats were anesthetized with sodium
pentobarbital (50 mg/kg, i.p., Kyoritsu Seiyaku, Tokyo,
Japan) and were perfused through the aorta with saline
(500 ml) followed by 4% paraformaldehyde (Wako,
Osaka, Japan) in 0.1 M phosphate buffer (PB, pH 7.4,
500 ml) at 1, 5 or 10 min after 0.5 M Glu was injected
into the whisker pad skin with a fine needle (n = 5 in
each time point). The Vc-C2 area was removed and
post-fixed in 4% paraformaldehyde for 1 day at 4°C. The
tissues were then transferred to 20% sucrose (Wako) in
saline for overnight for cryoprotection. Thirty μmt h i c k
sections were cut with a freezing microtome (Leica
Microsystems Japan, Tokyo, Japan). Every 4th section
was collected in phosphate-buffered saline (PBS, pH
7.4). Free-floating tissue sections were dipped in 10%
normal goat serum (NGS, Millipore, Billerica, MA) in
PBS for 12 hours at 4°C, and then incubated in rabbit
anti-Phospho-p44/42 MAP Kinase (Thr202/Tyr204)
antibody (1 : 1000, Cell Signaling, Danvers, MA) for 72
hours at 4°C. Next, the sections were incubated in bioti-
nylated goat anti-rabbit IgG (1 : 600; Vector Labora-
tories, Burlingame, CA) for 2 hours at room
temperature. After washing in PBS, the sections were
incubated in peroxidase-conjugated avidin-biotin com-
plex (1 : 100; Vector Laboratories) for 2 hours at room
temperature. They were then washed in 0.05 M tris buf-
fer (TB, pH 7.4), and dipped in 0.035% 3,3’-diaminoben-
zidine-tetra HCl (Sigma-Aldrich), 0.2% nickel
ammonium sulfate (Wako) and 0.05% hydrogen perox-
ide in 0.05 M TB. The sections were then washed in
PBS, and serially mounted on gelatin-coated slides. The
slides were dipped in a series from 50 to 100% alcohols
after dehydrated and then cover slipped.
Next, in order to evaluate the expression of pERK-IR
neurons following thermal stimulation, at 5 min after
0.1 M or 0.5 M Glu or vehicle was injected into the
whisker pad skin or the tongue, heat (50°C, duration: 60
sec, interval: 10 sec, train: 5) or cold (5°C, duration: 60
sec, interval: 10 sec, train: 5) stimulation was applied to
the whisker pad skin or the tongue at the site of Glu or
vehicle injection through a contact thermal probe (n = 5
in each group). Five min after stimulation, rats were
perfused and pERK immunohistochemistry was carried
out, as described above. To study the effect of Glu injec-
tion on pERK-IR cell expression, rats were also perfused
5 min after Glu or vehicle injection into the whisker
pad skin and tongue, and Vc and C1-C2 sections were
processed for pERK immunohistochemistry (n = 5 in
each group).
The pERK-IR neurons were counted by Neurolucida
Explorer (MicroBrightField, Williston, VT). Every 720
μm sections and 2 sections before and after 720 μm
were collected and the mean number of pERK-IR neu-
rons from these 3 sections was neurons calculated, and
the graphs of rostro-caudal distribution of pERK-IR neu-
rons were prepared. The mean number of pERK-IR neu-
rons in all the sections (27 sections/rat) was also
calculated for each animal and the mean number of
pERK-IR neurons in each group was compared.
Double immunofluorescence histochemistry was also
used to determine if the pERK-IR neurons expressed or
not a neuronal label. Five min after 0.5 M Glu injection
into the whisker pad skin, heat stimuli (50°C) were
applied at the site of the Glu injection (n = 5). Five min
after heat stimulation, rats were perfused through the
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hyde in 0.1 M PB (pH 7.4, 500 ml). The tissues were
then transferred to 20% sucrose (Wako) in saline for
overnight for cryoprotection. Thirty μm thick sections
were cut and processed for double-labeling immunohis-
tochemistry for pERK and the neuronal label NeuN.
Free-floating tissue sections were dipped in 10% NGS in
PBS for 12 hours at 4°C, and then incubated in rabbit
anti-Phospho-p44/42 MAPK Antibody (1 : 300) for 72
hours at 4°C. Next, the sections were mouse anti-NeuN
Antibody (1 : 1000, Chemicon, Temecula, CA) for 1
hour at room temperature and secondary antibodies
(FITC- and rhodamine-, 1 : 100; Jackson Immuno
Research, West Grove, PA) conjugated for 1 hour at
room temperature in a dark room. Then the sections
were washed in PBS 3 times for 5 min. The sections
were mounted on slides and cover slipped in Perma-
Fluor (Sigma-Aldrich). pERK-IR neurons and NeuN
immunoreactive neurons were observed by confocal
microscope (Carl Zeiss, Tokyo, Japan).
The expression of pERK-IR cells in Vc and C1-C2 to
heat or cold stimulation of the tongue in whisker pad
Glu-injected rats and heat stimulation of the whisker
pad skin in tongue Glu-injected rats were also analyzed
(n = 5 in each group).
The effect of injection of Glu receptor antagonist APV or
CNQX
Rats were anesthetized with 2% isoflurane with 100% O2
(for behavioral tests) or sodium pentobarbital (50 mg/
kg, i.p., for immunohistochemistry). The NMDA recep-
tor antagonist APV (Research Biochemicals Interna-
tional, Natick, MA), and the AMPA receptor antagonist
CNQX (Research Biochemicals International) were dis-
solved in isotonic saline to produce a 1 mM APV and a
10 μM CNQX solution respectively, in accordance with
previous studies [43,50]; isotonic saline was used as the
vehicle. Five min after 10 μl APV, CNQX or vehicle was
injected into ipsilateral whisker pad skin or tongue with
a fine needle (27 gauge), and 5 min after that 0.5 M Glu
was injected at the site of antagonist injection. At 5 min
after Glu injection, behavioral tests were performed on
ipsilateral side (n = 6 in each group), and another
groups of animals were perfused for subsequent exami-
nation of pERK-IR in Vc and C1-C2 neurons (n = 5 in
each group), as described above.
The effect of intrathecal (i.t.) injection of MAPK Kinase
(MEK) 1/2 inhibitor PD98059
In order to block the ERK phosphorylation in neurons
and TG primary afferent terminals in the Vc and C1-
C2, MEK1/2 inhibitor PD98059 (CalBiochem, San
Diego, CA) was i.t. administrated. PD98059 was dis-
solved in 20% dimethyl sulfoxide (DMSO) at a
concentration of 1 μg/μl( 3 . 7m M )a ss t o c ks o l u t i o n ,
and then further diluted to 0.1 μg/μl in 10% DMSO for
i.t. injection, in accordance with previous studies
[32,51]. A solution of 10% DMSO (in isotonic saline)
was used as vehicle control. Rats were anesthetized with
sodium pentobarbital (50 mg/kg, i.p.). The distance
from C4-C5 to C1-C2 was measured in pilot studies
and the length of a p10 polyethylene tube was adjusted
for this length (n = 2). The polyethylene tube was
inserted into the subdural space at the C4-C5 level and
the tip of the tube was located near the C1-C2 level.
After the experiments, vertebrae were removed and the
tip of the tube was confirmed at C1-C2. An osmotic
pressure pump was connected to the tube and placed
subcutaneously on the back. PD98059 or vehicle was
injected at a flow rate of 1.0 μl/hour for 7 days with the
osmotic pressure pump. One week after a pump filled
with PD98059 or vehicle pump placement, behavioral
tests were performed (n = 6 in each group) and pERK-
IR neurons was explored immunohistochemically (n = 5
in each group), as described above.
Statistical analysis
Results were presented as mean ± SEM. Statistical ana-
lysis was performed using one-way analysis of variance
(ANOVA) followed by Newman-Keuls test, Student’st -
test or Welch’s t-test as appropriate by using statistical
p r o g r a m( S i g m a S t a t3 . 5 ,S Y S T A T ,C h i c a g o ,I L ) .D i f f e r -
ences were considered significant at p < 0.05.
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